• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

C. R. Bard

edit

C. R. Bard, headquartered in Murray Hill, NJ, is a leading multinational developer, manufacturer and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology and surgical specialty products.

Recent Milestones

edit

• 
  C. R. Bard acquired Neomend. (10/23/12)
  Posted 10/25/12 at 6:25pm via dowjones.com
• 
  C. R. Bard acquired Lutonix. (12/20/11)
  Posted 12/30/11 at 5:33am via marketwatch.com

Videos

Screenshots

edit

Above: C. R. Bard
Uploaded: 12/30/11

Sources

1. C.R. Bard Acquires Neomend (pevc.dowjones.com) [edit]
2. CR Bard buys angioplasty-device maker Lutonix (marketwatch.com) [edit]